App-Quantinova.ai

Basis for Biochemical Discordance Between Activated Partial Thromboplastin Time and Anti-factor Xa in Patients with Continuous Flow Left Ventricular Assist Device on Unfractionated Heparin Infusion

Amy J Feng - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Utility of Cardiac Computed Tomography in Detecting Malposition of Left Ventricular Assist Devices Associated With Pump Thrombosis

Su-Yeon Choi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Remote Ischemic Conditioning, Applied During Recurrent Coronary Thrombosis Mimicking Unstable Angina, Improves Coronary Patency

Peter Whittaker - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

In-hospital Outcomes of Unstable Angina in Patients with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD), Years 2005-2011

Shasank Rijal - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

Prothrombotic Activity and Reduction in Coronary Flow Reserve Associated With Therapeutic Intracoronary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells is Ameliorated by Heparin Co-Administration in a Porcine Myocardial Infarction Model

Kenneth Martin - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Endothelial Overexpression of LOX-1 Protects From in vivo Arterial Thrombosis and Modulates Oct-1 and SIRT1 Expression

Giovani G Camici - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Responses to a Pre-PCI Screening Questionnaire Influence Stent Type Used During PCI

Sunil V Rao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Not Your Typical Atrial Flutter

Selcuk Adabag - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Double versus Provisional Stent Strategy for Coronary Bifurcation Using Drug-Eluting Stents: A Meta-Analysis of Randomized Controlled Trials

Ajay K Kaja - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Length of Stay and 30 Day Mortality in Patients Suffering an Uncomplicated ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention in New York State

Edward L. Hannan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Does Evidence Influence Practice in the Real World? Secular Trends in Indication for PCI and Use of Drug-Eluting vs. Bare-Metal Stents From 2006-2012

Jason L Salemi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Inhibition of vWF Secretion Prevents Microvascular Thrombosis in CLP Rodent Models of Sepsis

Martin Schlapfer - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Clinical Presentation, Management and Longitudinal Follow-Up of Neonatal and Infants With Coronary Artery Fistula - A Multicenter Study From the Coronary Artery Fistula Registry

Shelby Kutty - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Gender on Clinical Outcomes in Non-Valvular Atrial Fibrillation: Contemporary Perspective From the GARFIELD Registry

Samuel Z Goldhaber - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Evithrom

Comparison of Saphenous Vein Graft Occlusion and Stent Thrombosis: Discrepancies in Clinical Presentation, Procedural Characteristics and Clinical Outcomes

Thibault Lhermusier - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Longest Available Follow-Up of Drug-Eluting Stents in Real World Practice - Outcomes up to 12 Years From the DESIRE Registry

Amanda Sousa - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Roxithromycin

STOP-IT Study

John Kiely - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

rFVIIa

Finding Atrial Fibrillation in Stroke: Randomised Evaluation of Enhanced and Prolonged Holter Monitoring - Rationale and Design of Find-AFrandomised

Gotz Gelbrich - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TO-ACT trial)

Jose M Ferro - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Prospective Registry of Decompressive Surgery for Patients With Cerebral Venous Thrombosis (decompress-2)

Patricia Canhao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Filters

7277 Abstracts